Talk AI for Clinical Trials · Data
How AI Document Automation Can Support Our Clinical Trials for EU Submissions: EU-CTR Synopsis Case Study
Thu, Feb 6, 2025 · 9:05–9:25 AM EST Rosen Shingle Creek
About this session
In this session, BMS shares the innovation of creating a BOT to support clinical trial submissions to the EU Clinical Trial Regulation (EU-CTR). EU-CTR Regulations now requires submissions to include a synopsis and recommend the synopsis be understandable to a layperson. A BOT was developed to create the synopsis from the protocol and with AI technology, it converts the language to the required laymans terms. This is time saving technology to produce a document to support EUCTR submissions.
Speaker
-
Associate Director, Clinical Capabilities Manager · Bristol Myers Squibb Co
Speaker